Tirzepatide (Mounjaro, Zepbound) represents a newer class called dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonists
You may consume it on an empty stomach or alongside food, depending on your preference
Common reasons include BMI not meeting requirements, missing documentation, no qualifying comorbidities, excluded benefits, incomplete prior authorization, or step therapy requirements
It reduces the impact of UV radiation, airborne skin pollution, and other environmental factors that accelerate aging
Not all glutathione-boosting strategies are equivalent and the distinction between taking glutathione directly and taking a precursor like N-acetylcysteine (NAC) has real implications for GLP-1 users
Your guidance was invaluable during all the steps, decisions, and options that needed to be discussed and decided